Serb Sa

Calculating rank

USPTO Granted Patents = 7

Trademarks = 1

Forward Citations = 17

Loading Chart...

3 inventors (with patents filed for the assignee):

Marvin R Garovoy (7 out of 14 patents)

Peter E Haroldsen (7 out of 8 patents)

Donald G Musson (7 out of 7 patents)

7 patents: Sort by Forward Citations

1. 11873525 - Methods of administering 3,4-diaminopridine (2024-01-16),

2. 11845977 - Methods of administering 3,4-diaminopridine (2023-12-19),

3. 11274332 - Methods of administering 3,4-diaminopyridine (2022-03-15),

4. 11274331 - Methods of administering 3,4-diaminopyridine (2022-03-15),

5. 11268128 - Methods of administering 3,4-diaminopyridine (2022-03-08),

6. 11060128 - Methods of administering 3,4-diaminopyridine (2021-07-13),

7. 10793893 - Methods of administering 3,4-diaminopyridine (2020-10-06),

Company Overview

Serb Sa is a leading technology company specializing in a wide range of software and hardware solutions for businesses. With a focus on innovation and customer service, we strive to provide cutting-edge technologies that help businesses succeed in the digital age. Our team of experts is dedicated to delivering high-quality products and services that meet the unique needs of our clients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

7 Patents

#67 in Brussels

#338 in Belgium

Brussels, Belgium

Serb Sa

Forward Citations = 17

3 inventors:

Marvin R Garovoy (7 out of 14 patents)

Peter E Haroldsen (7 out of 8 patents)

Donald G Musson (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Serb Sa. Retrieved from https://idiyas.com/company/serb-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]